Skip to main content

Table 2 Multiple regression models for sensitivity analyses

From: Fetuin-A mediates the difference in adipose tissue insulin resistance between young adult pakistani and norwegian patients with type 2 diabetes

Model

β[95%CI]

P-value

NEFA-suppression

  

Model 1

  

  (Intercept)

60.3[41.4,79.3]

< 0.001

  Ethnicity

-27.3[-48.4,-6.3]

0.013

  T2DM duration

1.7[-0.3,3.8]

0.091

Model 2:

  

  (Intercept)

56.2[-0.6,112.9]

0.052

  Ethnicity

-23.2[-46.0,-0.5]

0.046

  HbA1c

2.0[-5.3,9.2]

0.582

Model 3:

  

  (Intercept)

60.1[19.1,101.0]

0.006

  Ethnicity

-20.2[-43.7,3.2]

0.088

  OAD

12.3[-31.5,56.1]

0.568

  OAD + NPH

11.2[-30.6,52.9]

0.586

Fetuin-A

  

Model 1

  

  (Intercept)

307.9[277.6,338.1]

< 0.001

  Ethnicity

45.9[12.3,79.5]

0.009

  T2DM duration

-0.7[-3.9,2.6]

0.679

Model 2:

  

  (Intercept)

269.3[184.3,354.3]

< 0.001

  Ethnicity

37.2[3.0,71.3]

0.034

  HbA1c

4.6[-6.3,15.4]

0.393

Model 3:

  

  (Intercept)

308.7[246.5,371.0]

0.000

  Ethnicity

42.5[6.8,78.2]

0.022

  OAD

-6.2[-72.9,60.5]

0.850

  OAD + NPH

-4.1[-67.5,59.4]

0.896

  1. CI confidence interval, OAD oral antidiabetic drugs metformin and/or sulfonylureas, NEFA Non-esterified fatty acid,  NPH Neutral protamine Hagedorn insulin, T2DM type 2 diabetes mellitus